Literature DB >> 11513080

Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT.

K Fukaya1, S Asahi, S Nagamori, M Sakaguchi, C Gao, M Miyazaki, M Namba.   

Abstract

Immortalized human hepatocytes that can retain functions of drug-metabolizing enzymes would be useful for medical and pharmacological studies and for constructing an artificial liver. The aim of this study was to establish immortalized human hepatocyte lines having differentiated liver-specific functions. pSVneo deoxyribonucleic acid, which contains large and small T genes in the early region of simian virus 40, was introduced into hepatocytes that had been obtained from the liver of a 21-wk-old fetus. Neomycin-resistant immortalized colonies were cloned and expanded to mass cultures to examine hepatic functions. Cells were cultured in a chemically defined serum-free medium, ASF104, which contains no peptides other than recombinant human transferrin and insulin. As a result, an immortal human hepatocyte cell line (OUMS-29) having liver-specific functions was established from one of the 13 clones. Expression of CYP 1A1 and 1A2 messenger ribonucleic acid by the cells was induced by treatment with benz[a]pyrene, 3-methylcholanthrene, and benz[a]anthracene. OUMS-29 cells had both the polycyclic aromatic hydrocarbon receptor (AhR) and AhR nuclear translocator. Consequently 7-ethoxyresorufin deethylase activity of the cells was induced time- and dose-dependently by these polycyclic aromatic hydrocarbons. This cell line is expected to be instrumental as an alternative method in animal experiments for studying hepatocarcinogenesis, drug metabolisms of liver cells, and hepatic toxicology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513080     DOI: 10.1007/BF02577541

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  17 in total

Review 1.  Hepatic stem cells.

Authors:  A J Strain; H A Crosby
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation.

Authors:  N D Theise; S Badve; R Saxena; O Henegariu; S Sell; J M Crawford; D S Krause
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

3.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.

Authors:  E Lagasse; H Connors; M Al-Dhalimy; M Reitsma; M Dohse; L Osborne; X Wang; M Finegold; I L Weissman; M Grompe
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

Review 4.  Molecular studies on the toxifying effects by genetically engineered cytochromes P450.

Authors:  J Doehmer; J T Buters; A Luch; V Soballa; W M Baird; H Morisson; J J Stegeman; A J Townsend; W F Greenlee; H R Glatt; A Seidel; J Jacob; H Greim
Journal:  Drug Metab Rev       Date:  1999-05       Impact factor: 4.518

5.  Bone marrow as a potential source of hepatic oval cells.

Authors:  B E Petersen; W C Bowen; K D Patrene; W M Mars; A K Sullivan; N Murase; S S Boggs; J S Greenberger; J P Goff
Journal:  Science       Date:  1999-05-14       Impact factor: 47.728

Review 6.  Liver stem cells: a two compartment system.

Authors:  M Alison
Journal:  Curr Opin Cell Biol       Date:  1998-12       Impact factor: 8.382

7.  Regulation of albumin gene expression in a series of rat hepatocyte cell lines immortalized by simian virus 40 and maintained in chemically defined medium.

Authors:  C D Woodworth; H C Isom
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

8.  Establishment of a human hepatocyte line derived from primary culture in a collagen gel sandwich culture system.

Authors:  Y Kono; S Yang; M Letarte; E A Roberts
Journal:  Exp Cell Res       Date:  1995-12       Impact factor: 3.905

9.  Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines.

Authors:  M Kawada; S Nagamori; H Aizaki; K Fukaya; M Niiya; T Matsuura; H Sujino; S Hasumura; H Yashida; S Mizutani; H Ikenaga
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

10.  Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens.

Authors:  A M Pfeifer; K E Cole; D T Smoot; A Weston; J D Groopman; P G Shields; J M Vignaud; M Juillerat; M M Lipsky; B F Trump
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more
  12 in total

1.  Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules.

Authors:  Julio A Gutierrez; Robert G Gish
Journal:  Transl Cancer Res       Date:  2013-12       Impact factor: 1.241

2.  Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.

Authors:  Chengcheng Ji; Katsuya Nagaoka; Jing Zou; Sarah Casulli; Shaolei Lu; Kevin Y Cao; Hongyu Zhang; Yoshifumi Iwagami; Rolf I Carlson; Keri Brooks; Jonathan Lawrence; William Mueller; Jack R Wands; Chiung-Kuei Huang
Journal:  FASEB J       Date:  2018-09-06       Impact factor: 5.191

3.  Establishment and characterisation of a novel bovine SV40 large T-antigen-transduced foetal hepatocyte-derived cell line.

Authors:  Alexander Gleich; Bastian Kaiser; Julia Schumann; Herbert Fuhrmann
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-12       Impact factor: 2.416

4.  Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.

Authors:  Eva Ramboer; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2015

Review 5.  Cellular Transplantation for Liver Diseases.

Authors:  Elizabeth Jameson
Journal:  Gastroenterology Res       Date:  2008-11-20

Review 6.  Human hepatocyte carcinogenesis (review).

Authors:  Hidenori Shiraha; Kazuhide Yamamoto; Masayoshi Namba
Journal:  Int J Oncol       Date:  2013-02-19       Impact factor: 5.650

7.  Functional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells.

Authors:  S B Nambotin; Y Tomimaru; P Merle; J R Wands; M Kim
Journal:  Oncogenesis       Date:  2012-10-22       Impact factor: 7.485

8.  Cell-based assay for the detection of chemically induced cellular stress by immortalized untransformed transgenic hepatocytes.

Authors:  Maria Grazia Sacco; Laura Amicone; Enrica Mira Catò; Daniela Filippini; Paolo Vezzoni; Marco Tripodi
Journal:  BMC Biotechnol       Date:  2004-03-19       Impact factor: 2.563

9.  Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.

Authors:  Chiung-Kuei Huang; Yoshifumi Iwagami; Arihiro Aihara; Waihong Chung; Suzanne de la Monte; John-Michael Thomas; Mark Olsen; Rolf Carlson; Tunan Yu; Xiaoqun Dong; Jack Wands
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

Review 10.  Strategies for immortalization of primary hepatocytes.

Authors:  Eva Ramboer; Bram De Craene; Joery De Kock; Tamara Vanhaecke; Geert Berx; Vera Rogiers; Mathieu Vinken
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.